维普中文期刊产品整合服务
77篇 您的检索式:作者名="Bateman N"
    题名 作者 年代 出处 被引量
1Refining pathological evaluation of neoadjuvant therapy for adenocarcinoma of the esophagus显示文摘AIM:To assess tumour regression grade(TRG)and lymph node downstaging to help define patients who benefit from neoadjuvant chemotherapy.METHODS:Two hundred and eighteen consecutive patients with adenocarcinoma of the esophagus or gastro-esophageal junction treated with surgery alone or neoadjuvant chemotherapy and surgery between 2005and 2011 at a single institution were reviewed.Triplet neoadjuvant chemotherapy consisting of platinum,fluoropyrimidine and anthracycline was considered for operable patients(World Health Organization performance status≤2)with clinical stage T2-4 N0-1.Response to neoadjuvant chemotherapy(NAC)was assessed using TRG,as described by Mandard et al.In addition lymph node downstaging was also assessed.Lymph node downstaging was defined by cN1 at diagnosis:assessed radiologically(computed tomography,positron emission tomography,endoscopic ultrasonography),then pathologically recorded as N0 after surgery;ypN0 if NAC given prior to surgery,or pN0if surgery alone.Patients were followed up for 5 years post surgery.Recurrence was defined radiologically,with or without pathological confirmation.An association was examined between t TRG and lymph node downstaging with disease free survival(DFS)and a comprehensive range of clinicopathological characteristics.RESULTS:Two hundred and eighteen patients underwent esophageal resection during the study interval with a mean follow up of 3 years(median follow up:2.552,95%CI:2.022-3.081).There was a 1.8%(n=4)inpatient mortality rate.One hundred and thirty-six(62.4%)patients received NAC,with 74.3%(n=101)of patients demonstrating some signs of pathological tumour regression(TRG 1-4)and 5.9%(n=8)having a complete pathological response.Forty four point one percent(n=60)had downstaging of their nodal disease(cN1 to ypN0),compared to only 15.9%(n=13)that underwent surgery alone(pre-operatively overstaged:cN1 to pN0),(P<0.0001).Response to NAC was associated with significantly increased DFS(mean DFS;TRG 1-2:5.1years,95%CI:4.6-5.6 vs TRG 3-5:2.8 years,95%CI:2.2-3.3,P<0.0001).Nodal down-staging conferred a significant DFS advantage for those patients with a poor primary tumour response to NAC(median DFS;TRG 3-5 and nodal down-staging:5.533 years,95%CI:3.558-7.531 vs TRG 3-5 and no nodal down-staging:1.114 years,95%CI:0.961-1.267,P<0.0001).CONCLUSION:Response to NAC in the primary tumour and in the lymph nodes are both independently associated with improved DFS.Fergus Noble Luke Nolan Adrian C Bateman James P Byrne Jamie J Kelly Ian S Bailey Donna M Sharland Charlotte N Rees Timothy J Iveson Tim J Underwood Andrew R Bateman 2013World Journal of Gastroenterology2013,19,48:4
2Nasal polyps:still more questions than answers显示文摘BATEMAN N D FAHY C WOOLFORD T J 2003J Laryngol Otol2003,117,:1
3Evaluation of Ruminally Protected Methionine and Lysine or Blood Meal and Fishmeal as Protein Sources for Lactating Holsteins显示文摘Bateman H D Spain J N Kerley M S 1999J Dairy Sci1999,82,8:1
4Evaluation of ruminally protected methionine and lysine or blood meal and fish meal as protein sources for lactating Holsteins显示文摘Bateman H D Spain J N Kerley M S 1999J Dairy Sci1999,82,:1
5Presentation of first branchial cleft anomalies:the Sheffield experience显示文摘Martinez Del Pero M Majumdar S Bateman N 2007Laryngol Otol2007,121,5:1
6The Pfam protein families database 显示文摘Punta M Coggill P C Eberhardt R Y Mistry J Tate J Boursnell C Pang N Forslund K Ceric G Clements J Hcger A Holm L Sonnhammer E L Eddy S R Bateman A Finn R D 2012Nucleic Acids Research2012,40,:1
7Evaluation of ruminally protected methionine and lysine or blood meal and fishmeal as protein sources for lactating Holsteins显示文摘Bateman H D Spain J N Kerley M S 1999Dairy Sci1999,82,:1
8Extrapyramidal reactions with metoclopramide 显示文摘D N Bateman M D Rawlins and J M Simpson 1985Br Med J (Clin Res Ed )1985,5291,:1
9Evaluation of ruminally protected methionine and lysine or blood meal and fish meal as protein sources for lactating Holsteins显示文摘 Spain J N Kerley M S Belyea R L and Marshall R T 1999J Dairy Sci1999,82,:1
10Nasal polyps; still more question than answer显示文摘BATEMAN N D FAHY C WOOLFORD T J 2003Laryngol Otol2003,117,:1
11Principles of crown lengthening surgery显示文摘Bateman GJ Karir N Saha S 2009Dent Update2009,36,3:1
12Evaluation of ruminally protected methionine and lysine or blood meal and fish meal as protein sources for lactating Holsteins显示文摘Bateman H G Spain J N Kerley M S 1999J Dairy Sci1999,82,10:1
13MEROPS: thepeptidase database显示文摘Rawlings N D Barrett A J Bateman A 2010Nucleic Acids Res2010,38,:1
14Electr ocardi ogram and cardiovascular changes in thi oridazine and chlor p r omazine pois oning显示文摘Strachan E M Kelly C A Bateman D N 2004Clin Pharmacol2004,60,:1
15Nasal polyps:still more questions than answers显示文摘BATEMAN N D FAHY C WOOLFORD T J 2003J Laryngol Otol2003,117,:1
16Domains in gene silencing and cell differentiation proteins: the novel PAZ domain and redefinition of the Piwi domain显示文摘Cerutti L Mian N Bateman A 2000Trends Biochem Sci2000,25,:1
17Principles of crown lengthe-ning sur-gery显示文摘Bateman GJ Karir N Saha S 2009Dent Update2009,36,3:1
18Use of a beryllium Hopkinson bar to characterize a piezoresistive aecelerom- eter in shock environments显示文摘Bateman V I Brown F A Davie N T 1996Journal of the Institute of Environmental Sciences1996,39,6:1
19Nasal polyps:still more questions than answers显示文摘BATEMAN N D FAHY C WOOLFORD T J 2003J Laryngol Otol2003,117,:1
20Intestinal tumor progression is associated with altered function of KLF5显示文摘BATEMAN N M TAN D PESTELL R G 0,,13:1
返回顶部 每页显示:
共4页 首页 上一页 第1页 下一页 末页 /4 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费